References 1. van Asbeck EC, Clemons KV, Stevens DA: Candida parapsilosis: a review of its epidemiology, pathogenesis, clinical aspects, typing and antimicrobial susceptibility. Crit Rev Microbiol 2009, 35:283–309.PubMedCrossRef 2. Pfaller

MA, Jones RN, Doern GV, Fluit AC, Verhoef J, Sader HS, Messer SA, Houston A, Coffman S, Hollis RJ: International surveillance of blood stream infections due to Candida species in the European SENTRY Program: species distribution and antifungal susceptibility including the investigational triazole and echinocandin agents. SENTRY Participant Group (Europe). Diagn Microbiol Infect Dis 1999, 35:19–25.PubMedCrossRef 3. Trofa D, Gacser A, Nosanchuk JD: Candida parapsilosis, an emerging fungal pathogen. Clin Microbiol Rev 2008, 21:606–625.PubMedCrossRef 4. Pfaller

MA, Moet GJ, Messer SA, Jones RN, Castanheira M: Candida Bloodstream Infections: Comparison of Species Distribution GSK126 manufacturer and Antifungal Resistance in Community Onset and Nosocomial Isolates in the SENTRY Antimicrobial Surveillance Program (2008–2009). Antimicrob Agents Chemother 2010. 5. Clark TA, Slavinski SA, Morgan J, Lott T, Arthington-Skaggs BA, Brandt ME, Webb RM, Currier M, Flowers RH, Fridkin SK, Hajjeh RA: Epidemiologic and molecular characterization of an outbreak selleck compound of Candida parapsilosis bloodstream infections in a community hospital. J Clin Microbiol 2004, 42:4468–4472.PubMedCrossRef 6. Clerihew L, Lamagni TL, Brocklehurst P, McGuire W: Candida parapsilosis infection in very low birthweight selleck chemical infants. Arch Dis Child Fetal Neonatal Ed 2007, 92:F127–129.PubMedCrossRef 7. Benjamin DK Jr, Garges H, Steinbach WJ: Candida bloodstream infection in neonates. Semin Perinatol 2003, 27:375–383.PubMedCrossRef 8. Smith PB, Steinbach

WJ, Benjamin DK Jr: Neonatal candidiasis. Infect Dis Clin North Am 2005, 19:603–615.PubMedCrossRef TCL 9. Newman SL, Holly A: Candida albicans is phagocytosed, killed, and processed for antigen presentation by human dendritic cells. Infect Immun 2001, 69:6813–6822.PubMedCrossRef 10. Pivarcsi A, Bodai L, Rethi B, Kenderessy-Szabo A, Koreck A, Szell M, Beer Z, Bata-Csorgoo Z, Magocsi M, Rajnavolgyi E, Dobozy A, Kemeny L: Expression and function of Toll-like receptors 2 and 4 in human keratinocytes. Int Immunol 2003, 15:721–730.PubMedCrossRef 11. Netea MG, Brown GD, Kullberg BJ, Gow NA: An integrated model of the recognition of Candida albicans by the innate immune system. Nat Rev Microbiol 2008, 6:67–78.PubMedCrossRef 12. Neumann AK, Jacobson K: A novel pseudopodial component of the dendritic cell anti-fungal response: the fungipod. PLoS Pathog 2010, 6:e1000760.PubMedCrossRef 13. Gacser A, Trofa D, Schafer W, Nosanchuk JD: Targeted gene deletion in Candida parapsilosis demonstrates the role of secreted lipase in virulence. J Clin Invest 2007, 117:3049–3058.PubMedCrossRef 14.